1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
2Regional Knowledge Hub, and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
Background While colorectal cancer (CRC) is one of the most preventable causes of cancer mortality, it is one of the leading causes of cancer death in Canada where CRC screening uptake is suboptimal. Given the increased rate of mortality and morbidity among mental health patients, their condition could be a potential barrier to CRC screening due to greater difficulties in adhering to behaviours related to long-term health goals. Using a population-based study among Canadians, we hypothesize that self-perceived mental health (SPMH) status and fecal occult blood test (FOBT) uptake for the screening of CRC are associated.
Methods The current study is cross-sectional and utilised data from the Canadian Community Health Survey 2011-2012. Multinomial logistic regression analysis was undertaken to assess whether SPMH is independently associated with FOBT uptake among a representative sample of 11 386 respondents aged 50-74 years.
Results Nearly half of the respondents reported having ever had FOBT for CRC screening, including 37.28% who have been screened within two years of the survey and 12.41% who had been screened more than two years preceding the survey. Respondents who reported excellent mental health were more likely to have ever been screened two years or more before the survey (adjusted odds ratio [AOR] = 2.08; 95% CI, 1.00-4.43) and to have been screened in the last two years preceding the survey (AOR = 1.53; 95% CI, 0.86-2.71) than those reported poor mental health status.
Conclusion This study supports the association between SPMH status and FOBT uptake for CRC screening. While the efforts to maximize CRC screening uptake should be deployed to all eligible people, those with poor mental health may need more attention.
Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541-1549. doi:10.1111/j.1572-0241.2008.01875.x
Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics;2015.
Canadian Partnership Against Cancer. An update on colorectal cancer screening in Canada;2011.
Cole SR, Zajac I, Gregory T, et al. Psychosocial variables associated with colorectal cancer screening in South Australia. Int J Behav Med. 2011;18(4):302-309. doi:10.1007/s12529-010-9101-1
Dear K, Scott L, Chambers S, Corbett MC, Taupin D. Perception of colorectal cancer risk does not enhance participation in screening. Therap Adv Gastroenterol. 2008;1(3):157-167. doi:10.1177/1756283x08097776
Guessous I, Dash C, Lapin P, et al. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50(1):3-10. doi:10.1016/j.ypmed.2009.12.005
McCaffery K, Wardle J, Nadel M, Atkin W. Socioeconomic variation in participation in colorectal cancer screening. J Med Screen. 2002;9(3):104-108. doi:10.1136/jms.9.3.104
Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer. 2004;100(10):2093-2103. doi:10.1002/cncr.20276
Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiology Biomarkers & Prevention. 2008;17(7):1623-1630. doi:10.1158/1055-9965.epi-07-2838
Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004;38(5):536-550. doi:10.1016/j.ypmed.2003.12.011
Wardle J, Miles A, Atkin W. Gender differences in utilization of colorectal cancer screening. J Med Screen. 2005;12(1):20-27. doi:10.1258/0969141053279158
Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R. Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002;23(1):28-35. doi:10.1016/s0749-3797(02)00444-0
Calderwood AH, Bacic J, Kazis LE, Cabral H. Association between self-reported depression and screening colonoscopy participation. J Ambul Care Manage. 2013;36(4):345. doi:10.1097/jac.0b013e3182a3e73f
Kodl MM, Powell AA, Noorbaloochi S, Grill JP, Bangerter AK, Partin MR. Mental health, frequency of healthcare visits, and colorectal cancer screening. Med Care. 2010;48(10):934-939. doi:10.1097/mlr.0b013e3181e57901
Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.
Carney CP, Jones LE. The influence of type and severity of mental illness on receipt of screening mammography. J Gen Intern Med. 2006;21(10):1097-1104. doi:10.1111/j.1525-1497.2006.00565.x
Egede LE, Grubaugh AL, Ellis C. The effect of major depression on preventive care and quality of life among adults with diabetes. Gen Hosp Psychiatry. 2010;32(6):563-569. doi:10.1016/j.genhosppsych.2010.08.002
Leiferman JA, Pheley AM. The effect of mental distress on women's preventive health behaviors. Am J Health Promot. 2006;20(3):196-199.
Lord O, Malone D, Mitchell AJ. Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. Gen Hosp Psychiatry. 2010;32(5):519-543. doi:10.1016/j.genhosppsych.2010.04.004
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.
Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54(3):216-226.
Ahmad F, Jhajj AK, Stewart DE, Burghardt M, Bierman AS. Single item measures of self-rated mental health: a scoping review. BMC Health Serv Res.. 2014;14(1):398. doi:10.1186/1472-6963-14-398
Bond J, Dickinson HO, Matthews F, Jagger C, Brayne C, CFAS M. Self-rated health status as a predictor of death, functional and cognitive impairment: a longitudinal cohort study. Eur J Ageing. 2006;3(4):193-206. doi:10.1007/s10433-006-0039-8
An A, Watts D. New SAS procedures for analysis of sample survey data. SUGI Proceedings. Cary, NC: SAS Institute Inc; 1998.
Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ. The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc. 2002;50(10):1651-1658. doi:10.1046/j.1532-5415.2002.50456.x
Yee EF, White R, Lee S-J, et al. Mental illness: is there an association with cancer screening among women veterans? Womens Health Issues. 2011;21(4):S195-S202. doi:10.1016/j.whi.2011.04.027
Naggara O, Raymond J, Guilbert F, Roy D, Weill A, Altman DG. Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms. Am J Neuroradiol. 2011;32(3):437-440. doi:10.3174/ajnr.a2425
Stecker T, Fortney JC, Prajapati S. How depression influences the receipt of primary care services among women: a propensity score analysis. J Womens Health (Larchmt). 2007;16(2):198-205.
Ferlitsch M, Reinhart K, Pramhas S, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 2011;306(12):1352-1358. doi:10.1001/jama.2011.1362
Green CA, Pope CR. Gender, psychosocial factors and the use of medical services: a longitudinal analysis. Soc Sci Med. 1999;48(10):1363-1372. doi:10.1016/S0277-9536(98)00440-7
Machlin S, Cohen J, Elixhauser A, Beauregard K, Steiner C. Sensitivity of household reported medical conditions in the medical expenditure panel survey. Med Care. 2009;47(6):618-625.
Khoja S, McGregor SE, Hilsden RJ. Validation of self-reported history of colorectal cancer screening. Can Fam Physician. 2007;53(7):1192-1197.
Partin MR, Grill J, Noorbaloochi S, et al. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiology Biomarkers & Prevention. 2008;17(4):768-776. doi:10.1158/1055-9965.epi-07-0759
The University of British Columbia Board of Governors. Policy No. 89: Research Involving Human Participants; 2002.